Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
128M
-
Shares change
-
+519K
-
Total reported value, excl. options
-
$507M
-
Value change
-
+$988K
-
Put/Call ratio
-
7.25
-
Number of buys
-
51
-
Number of sells
-
-44
-
Price
-
$3.95
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q4 2022
133 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128M shares
of 266M outstanding shares and own 48.16% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (34.2M shares), BAILLIE GIFFORD & CO (10.8M shares), CANADA PENSION PLAN INVESTMENT BOARD (10.2M shares), FMR LLC (9.17M shares), VANGUARD GROUP INC (8.97M shares), BlackRock Inc. (7.79M shares), STATE STREET CORP (6.79M shares), PUBLIC SECTOR PENSION INVESTMENT BOARD (6.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.26M shares), and Crestline Management, LP (3.37M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.